OUR WORLDWIDE TEAM
Anpac Bio employs nearly 70 dynamic, creative, innovative, self-motivated and successful scientists, researchers, engineers, sales, marketing, and business development experts worldwide. Educated at internationally-acclaimed, universities and educational institutions (such as Yale University); and recruited from Fortune 500, NYSE- and NASDAQ-listed corporations (including General Electric, Bayer, Roche, etc.); Anpac employees are recognized leaders in the medical device industry and technology industries.
Collectively, Anpac Bio’s employees have filed over 300 patents, (with more than 200 issued to date). The company’s multi-disciplinary, collaborative approach results in a strong track record of successful innovation, leading to laboratory trials, pilot plant development, full-scale manufacturing, and market growth.
Anpac Bio-Medical’s scientists have been invited to share the company’s breakthrough CDA research results at respected international health and science events such as the Nobel Prize Laureate Summit on Biomedical Science, the American Society of Clinical Oncology, and the international ASCO Breast Cancer Symposium.